Perspective Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Perspective Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2023.
  • Perspective Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $587K, a 44.1% decline year-over-year.
  • Perspective Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.32M.
  • Perspective Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.14M, a 306% increase from 2022.
  • Perspective Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $775K, a 101% increase from 2021.
  • Perspective Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $386K, a 22% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.14M +$2.37M +306% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $775K +$389K +101% Jul 1, 2021 Jun 30, 2022 10-K 2024-03-28
2021 $386K -$109K -22% Jul 1, 2020 Jun 30, 2021 10-KT 2023-05-01
2020 $495K +$75K +17.9% Jul 1, 2019 Jun 30, 2020 10-KT 2023-05-01
2019 $420K +$16K +3.96% Jul 1, 2018 Jun 30, 2019 10-K 2021-09-27
2018 $404K +$32K +8.6% Jul 1, 2017 Jun 30, 2018 10-K 2020-09-25
2017 $372K +$82K +28.3% Jul 1, 2016 Jun 30, 2017 10-K 2019-09-27
2016 $290K +$85K +41.5% Jul 1, 2015 Jun 30, 2016 10-K 2018-09-26
2015 $205K +$19K +10.2% Jul 1, 2014 Jun 30, 2015 10-K 2017-09-28
2014 $186K +$77.6K +71.7% Jul 1, 2013 Jun 30, 2014 10-K 2016-09-09
2013 $108K -$65K -37.5% Jul 1, 2012 Jun 30, 2013 10-K 2015-09-14
2012 $173K Jul 1, 2011 Jun 30, 2012 10-K 2013-09-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.